CD4 on the Road to Coreceptor Status

Abstract

The advent of mAb technology in the late 1970s initiated a wave of discovery that led to the identification of many important cell surface proteins that defined unique cellular populations with restricted functions ([1][1]). In the early 1980s, Abs to T4 and T8 (now known as CD4 and CD8,